openPR Logo
Press release

Sepha's new EZ Blister+ enables 21 CFR Part 11 compliant micro-batches

03-24-2022 03:33 PM CET | Health & Medicine

Press release from: Scott PR

Sepha, the Northern Ireland-based manufacturer of pharmaceutical packaging and equipment, has developed a new compact small-batch blister packaging machine with full traceability and electronic data storage capabilities. The EZ Blister+ meets increased demand for 21 CFR Part 11 compliant micro-batches throughout the blister production lifecycle, from R&D right through to commercial production. It will launch via a live webinar on 6th April (https://app.livestorm.co/sepha/digitalisation-of-low-volume-blister-packaging).

The EZ+ Blister answers calls from larger pharmaceutical manufacturers and Contract Manufacturing Organisations (CMOs) for a small-scale blister packaging machine with 21 CFR Part 11 capabilities. Demand for small batches of pharmaceuticals and medical devices has exploded in recent years, and these businesses are struggling to accommodate increasingly frequent requests for low volumes on their high-speed blister lines.

Manufacturers have historically relied on lab-scale blister packaging machines to produce small quantities of drugs and medical devices for samples or clinical trials. However, most bench-top machines are not intended for commercial production, and although capable of fulfilling small orders, do not have the necessary software architecture for demonstrating 21 CFR Part 11 compliance. Therefore, manufacturers are left with no choice but to use their high-speed lines, which cannot be justified in terms of line clearance and changeover times.

The result of 12 months of R&D, the EZ Blister+ bridges this gap, providing a 21 CFR Part 11-ready system for producing small batches with electronic signatures and documentation. The machine is an intelligent evolution of the EZ Blister, Sepha's flagship low volume blister packaging solution. It provides the same proven blister packaging performance, but with added software capabilities that enable the creation of electronic signatures, batch reports, audit trails and other electronic documentation. The Structured Query Language (SQL) database system at the core of the EZ Blister+ powers a host of applications on the machine, from recipe creation and management to reporting, as well as facilitating integration with factory networks and Management Execution Systems (MES).

Paul Smith, Managing Director of Sepha, says: "The message that we are getting loud and clear is that pharmaceutical manufacturers want electronic record keeping functionality and digital connectivity from all of their packaging equipment - not just their highly automated, high-speed lines. They are looking to create digital eco-systems in which all systems are connected and centrally controlled, so that when the auditors come knocking, they can easily show compliance.
At the same time, the trend towards small batches is gaining momentum as drugs become more specialised and personalised. These two trends converge in the EZ Blister+, which we believe to be the first micro-batch blister packaging machine to offer 21 CFR Part 11 functionality."

He continues: "Our R&D team has digitised the EZ Blister machine, elevating it to a highly intelligent system that can record all data that is necessary for traceability purposes and connect with a company's network so site personnel can have full visibility of what is going on during blister production."

The EZ Blister+ employs proven forming, sealing and cutting techniques to ensure packs are of the same quality and integrity as those produced on large blister packaging lines. Blister trays or cards are thermoformed or coldformed according to the exact specification of the product, sealed with pre-cut pieces of lidding material using knurled or flat heated sealing plates, then cut and perforated using a precision die-cutter. Tablets, capsules, ampoules and other products can all be packaged on this compact, versatile system.

The new EZ Blister+ will be launched via a live webinar on 6th April 2022, register here: https://app.livestorm.co/sepha/digitalisation-of-low-volume-blister-packaging.

The Scott Partnership, 1 Whiteside, Station Road, Holmes Chapel, Cheshire
Lucy Shaw, lrs@scottpr.com

Founded in 1980, Sepha provides innovative, non-destructive leak testing solutions, lab scale packaging solutions and deblistering machines for recovery of high value product. The company has established a strong global sales customer service and support network in all major pharmaceutical manufacturing markets. The company works with most of the world's top pharmaceutical companies helping them to improve quality assurance procedures and to reduce manufacturing costs, enabling clients to efficiently meet the stringent regulatory requirements of the industry.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Sepha's new EZ Blister+ enables 21 CFR Part 11 compliant micro-batches here

News-ID: 2585681 • Views:

More Releases from Scott PR

Cmed and Larix fully integrated into Aixial Group, the CRO solution of ALTEN Gro …
Following its acquisition of Larix in 2019 and Cmed Group in 2021, Aixial Group has become a leading mid-size, global CRO, with strong US and European presence and more than 1,000 employees. With over 30 years' experience in successful project delivery, Aixial Group continues to grow with the full integration of Larix and Cmed enabling it to extend its expertise and offerings, with more options for biotech and pharma sponsors at
Clinical trial platform provider encapsia welcomes new COO
Horsham, United Kingdom, 20th December 2022: Clinical trial management solutions provider, encapsia, has announced the appointment of Francis Destin as its new Chief Operating Officer. Francis brings more than 20 years of expertise to the role, specialising in the management of data-related projects in clinical trials and statistical analysis software. His adoption of a future-facing approach to clinical research supports encapsia's vision of transforming clinical trials for the benefit of
Scitara Corp. raises $15m in Series B Financing to disrupt the laboratory data i …
Scitara Corp, a proven innovator in laboratory digital transformation, today announces the closing of its Series B round with an additional investment of $15m. Led by existing investor Northpond Ventures, with participation from Flybridge Capital and experienced financial advisors to the biopharma and life science tools industry, the funding will springboard Scitara’s ambitious growth plans for 2022 and beyond to solve the laboratory data integration challenge. Scitara’s growth has been fuelled
Global Pharmaceutical Company proves validity of AI in life sciences through Pan …
A Senior Principal Data Scientist from a leading global pharmaceutical company showcased its success stories of using Pangaea Data’s novel artificial intelligence driven product, PIES (Pangaea’s Intelligence Extractor and Summarization). The presentation took place at the Bio-IT World Conference and Expo on 21st September 2021 and demonstrated that PIES’s inherent Natural Language Generation (NLG) methods provide clinicians and researchers with the ability to generate clinical narratives automatically based on discrete

All 5 Releases


More Releases for Blister

Key Trends Reshaping the Blister Packaging Market: Sustainable Packaging Innovat …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations. Blister Packaging Market Size Growth Forecast: What to Expect by 2025? The magnitude of the blister packaging market has experienced significant growth recently. The size of the market is forecasted to increase from $24.08 billion in 2024 to $25.89 billion in 2025, boasting a compound annual growth rate (CAGR) of 7.5%. The previous increase
Pharmaceutical Industry Boom Fuels Growth Of Blister Packaging Market: A Key Dri …
The Blister Packaging Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Current Blister Packaging Market Size and Its Estimated Growth Rate? In recent times, there has been robust growth in the size of the blister packaging market. This market, which today stands at
https://us.qyresearch.com/reports/355014/blister-lidding-foil
QY Research latest released a report about Blister Lidding Foil. This report focuses on global and United States Blister Lidding Foil, also covers the segmentation data of other regions in regional level and county level. Key Market Segmentation Blister Lidding Foil is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Blister Lidding Foil will be able to gain the upper hand as
2028 Blister Packaging Industry Report Growth Forecasts
2028 Blister Packaging Industry Report Growth Forecasts Blister packaging solution is molded pieces of plastics mostly sealed to a sheet of paper or aluminum and are used to pack products such as tablets or high-volume of low-price consumer electronic products. Mainly, three types of materials are used in this type of packaging, plastic substrates as a forming film and paper & paperboard or aluminum as lidding materials. Browse complete “Blister Packaging Market”
Pharmaceutical Blister Packaging Market 2021 | Detailed Report
Global Pharmaceutical Blister Packaging Market 2021-2027, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. An exclusive data offered in this report is collected by research and industry experts team. Get Free Sample PDF (including full TOC, Tables and
Rotary Blister to Emerge as Preferred Equipment for Manufacturers of Blister Pac …
The report highlights the key factors responsible for shaping the blister packaging equipment market across various regions. The detailed analysis based on product, process, equipment, technology, and end use is included in the report. The transition requirement from traditional blister packaging equipment line with advance technology based equipment line is driving the global market of blister packaging equipment. Robotic installation in blister packaging lines offers high-speed efficiency and reduces manual